semaglutide bloating Is Your Ultimate Option For Weight Loss? GLP-1 Bloating: Causes and Management
Description
Adherence may continue to present a challenge, particularly in younger age groups
2024 doi: 10.1016/j.ajog.2024.08.024
Weight loss can lead to bone loss Kohrts research points to one important principle: Weight loss equals bone loss, she said
Discontinued and pipeline GLP-1 medications Discontinued: Albiglutide (Tanzeum): Approved 2014, voluntarily withdrawn 2018
Branded GLP-1: Cost, Access, and Regulatory Differences Compounded and branded GLP-1 medications operate under fundamentally different regulatory and economic models
In separate studies, oral Wegovy led to roughly 14% body weight reduction over 64 weeks, while Foundayo achieved about an 11% reduction over 72 weeks
